153O - M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype

Autor: Yoo, C., Oh, D.-Y., Choi, H.J., Kudo, M., Ueno, M., Kondo, S., Chen, L.-T., Osada, M., Helwig, C., Dussault, I., Ikeda, M.
Zdroj: In Annals of Oncology November 2018 29 Supplement 9:ix48-ix49
Databáze: ScienceDirect